Literature DB >> 8709206

Analysis of early region 3 mutants of mouse adenovirus type 1.

C W Beard1, K R Spindler.   

Abstract

Early region 3 (E3) of mouse adenovirus type 1 has the potential to produce three proteins which have identical amino termini but unique carboxy-terminal sequences. Three recombinant deletion viruses were constructed so that each could produce only one of the three E3 proteins. A fourth mutant that should produce no E3 proteins was also constructed. These recombinants were able to grow in mouse 3T6 cells and produced wild-type levels of viral mRNAs and proteins except for those specifically deleted by the mutations. Early mRNA production from the mutant viruses was analyzed by reverse transcriptase PCR and confirmed that each deletion mutant would be able to produce only one of the three E3 proteins. Late mRNA production was analyzed by Northern (RNA) blotting and found to be similar in wild-type and mutant viruses. Capsid morphology was unaltered in the mutant viruses as seen by electron microscopy. Immunoprecipitation of E3 proteins from infections of mouse 3T6 cells using an antiserum specific for all three E3 proteins was used to examine the effect of the introduced mutations on protein expression. Two mutants produced only one class of E3 protein as predicted from their specific mutations and mRNA expression profiles. One mutant virus failed to produce any detectable E3 proteins. The predicted E3-null mutant was found to be leaky and could produce low levels of E3 proteins. Outbred Swiss mice were infected with the E3 mutant viruses to determine if the E3 proteins have an effect on the pathogenicity of the virus in mice. All of the mutants showed decreased pathogenicity as determined by increased 50% lethal doses, indicating that the proteins of the E3 region are important determinants of the pathogenesis of mouse adenovirus in its natural host.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709206      PMCID: PMC190604          DOI: 10.1128/JVI.70.9.5867-5874.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Role of the adenovirus E3-19k conserved region in binding major histocompatibility complex class I molecules.

Authors:  P Flomenberg; J Szmulewicz; E Gutierrez; H Lupatkin
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Transcription mapping of mouse adenovirus type 1 early region 4.

Authors:  S C Kring; A O Ball; K R Spindler
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

3.  Suggestions for "safe" residue substitutions in site-directed mutagenesis.

Authors:  D Bordo; P Argos
Journal:  J Mol Biol       Date:  1991-02-20       Impact factor: 5.469

Review 4.  Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions.

Authors:  W S Wold; L R Gooding
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

5.  Sequence analysis of putative E3 and fiber genomic regions of two strains of canine adenovirus type 1.

Authors:  B P Dragulev; S Sira; M G Abouhaidar; J B Campbell
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

6.  The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon.

Authors:  J Zemmour; A M Little; D J Schendel; P Parham
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

7.  Sequence and structural analysis of murine adenovirus type 1 hexon.

Authors:  J M Weber; F Cai; R Murali; R M Burnett
Journal:  J Gen Virol       Date:  1994-01       Impact factor: 3.891

8.  Association of vaccinia virus-expressed adenovirus E3-19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model.

Authors:  A Grunhaus; S Cho; M S Horwitz
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

9.  Primary structure of the murine adenovirus type 1 proteinase.

Authors:  F Cai; D Tang; J M Weber
Journal:  Biochim Biophys Acta       Date:  1992-02-11

10.  The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model.

Authors:  J Tufariello; S Cho; M S Horwitz
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more
  11 in total

1.  SJL/J mice are highly susceptible to infection by mouse adenovirus type 1.

Authors:  K R Spindler; L Fang; M L Moore; G N Hirsch; C C Brown; A Kajon
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 2.  Murine adenoviruses: tools for studying adenovirus pathogenesis in a natural host.

Authors:  Silvio Hemmi; Katherine R Spindler
Journal:  FEBS Lett       Date:  2019-12-06       Impact factor: 4.124

3.  Acute respiratory infection with mouse adenovirus type 1.

Authors:  Jason B Weinberg; Gregory S Stempfle; John E Wilkinson; John G Younger; Katherine R Spindler
Journal:  Virology       Date:  2005-09-30       Impact factor: 3.616

4.  In vitro and in vivo characterization of a mouse adenovirus type 1 early region 3 null mutant.

Authors:  A N Cauthen; C C Brown; K R Spindler
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

5.  Oral Vaccination with Replication-Competent Adenovirus in Mice Reveals Dissemination of the Viral Vaccine beyond the Gastrointestinal Tract.

Authors:  Emeline Goffin; Justine Javaux; Eric Destexhe; Carla D Pretto; Katherine R Spindler; Bénédicte Machiels; Laurent Gillet
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

6.  The role of mouse adenovirus type 1 early region 1A in acute and persistent infections in mice.

Authors:  K Smith; C C Brown; K R Spindler
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  T cells cause acute immunopathology and are required for long-term survival in mouse adenovirus type 1-induced encephalomyelitis.

Authors:  Martin L Moore; Corrie C Brown; Katherine R Spindler
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 8.  Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.

Authors:  Estrella Lopez-Gordo; Iva I Podgorski; Nicholas Downes; Ramon Alemany
Journal:  Hum Gene Ther       Date:  2014-03-25       Impact factor: 5.695

9.  Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors.

Authors:  Michael Robinson; Betty Li; Ying Ge; Derek Ko; Satya Yendluri; Thomas Harding; Melinda VanRoey; Katherine R Spindler; Karin Jooss
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

10.  Combinatorial modulation of initial codons for improved zeaxanthin synthetic pathway efficiency in Escherichia coli.

Authors:  Zaiqiang Wu; Dongdong Zhao; Siwei Li; Junsong Wang; Changhao Bi; Xueli Zhang
Journal:  Microbiologyopen       Date:  2019-09-18       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.